Fixed-Dose Netupitant and Palonosetron for Chronic Nausea and Vomiting in Cancer Patients
Phase of Trial: Phase II/III
Latest Information Update: 10 May 2017
At a glance
- Drugs Netupitant/palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 04 May 2017 Planned End Date changed from 1 Jun 2019 to 1 May 2019.
- 04 May 2017 Planned primary completion date changed from 1 Jun 2019 to 1 May 2019.
- 04 May 2017 Status changed from not yet recruiting to recruiting.